Demonstration of sucralfate-mediated preservation of growth factor bioactivity in the presence of low pH with a human gastric epithelial cell line (AGS)

Pharmaceutical Research

Volumn 13, Issue 7, 1996, Pages 1122-1126

  Sheng, Huaibao ^a   Shah, Praful K ^b   Audus, Kenneth L ^a  

^a UNIVERSITY OF KANSAS   (United States)

^b SANOFI   (France)

Author keywords

AGS; Basic fibroblast growth factor; Epidermal growth factor; Gastric epithelium; Sucralfate

Indexed keywords

ALUMINUM HYDROXIDE; BASIC FIBROBLAST GROWTH FACTOR; RECOMBINANT EPIDERMAL GROWTH FACTOR; SUCRALFATE;

ARTICLE; CELL CULTURE; CELL GROWTH; CELL PROLIFERATION; CONTROLLED STUDY; DRUG ACTIVITY; DRUG MECHANISM; HUMAN; HUMAN CELL; PH; PRESERVATION; PRIORITY JOURNAL; STOMACH EPITHELIUM;

ANTI-ULCER AGENTS; CELL DIVISION; DRUG EVALUATION, PRECLINICAL; EPIDERMAL GROWTH FACTOR; EPITHELIAL CELLS; EPITHELIUM; FIBROBLAST GROWTH FACTOR 2; GASTRIC MUCOSA; HUMANS; HYDROGEN-ION CONCENTRATION; MODELS, BIOLOGICAL; SUCRALFATE; TUMOR CELLS, CULTURED;

EID: 0029764188     PISSN: 07248741     EISSN: None     Source Type: Journal    
DOI: 10.1023/A:1016035513974     Document Type: Article

References (18)

1. P. ten Dijke and K. K. Iwata. Growth factors for wound-healing. Biotechnology 7:793-798 (1989).
2. P. K. Tsai, D. B. Volkin, J. M. Dabora, K. C. Thompson, M. W. Bruner, J. O. Gress, B. Matuszewska, M. Keogan, J. V. Bondi, and C. R. Middaugh. Formulation design of acidic fibroblast growth factor. Pharm. Res. 10:649-659 (1993).
3. D. B. Volkin, A. M. Verticelli, K. E. Marfia, C. J. Burke, H. Mach, and C. R. Middaugh. Sucralfate and soluble sucrose octa-sulfate bind and stabilize acidic fibroblast growth factor. Biochim. Biophys. Acta 1203:18-26 (1993).
4. K. Fukunaga, S. Hijikata, K. Ishimura, R. Sonoda, T. Irie, and K. Uekama. Aluminum β-cyclodextrin sulphate as a stabilizer and sustained-release carrier for basic fibroblast growth factor. J. Pharm. Pharmacol. 46:168-171 (1994).
5. D. Gospodarowicz and J. Cheng. Heparin protects basic and acidic FGF from inactivation. J. Cell. Physiol. 128:475-484 (1986).
6. J. Folkman, S. Szabo, M. Stovroff, P. Mcneil, W. Li, and Y. Shing. Duodenal ulcer: discovery of a new mechanism and development of angiogenic therapy that accelerates healing. Ann. Surg. 214:414-427 (1991).
7. S. J. Prestrelski, G. M. Fox, and T. Arakawa. Binding of heparin to basic fibroblast growth factor induces a conformational change. Arch. Biochem. Biophys. Acta 293:314-319 (1992).
8. S. Faham, R. E. Hileman, J. R. Fromm, R. J. Linhardt, and D. C. Rees. Heparin structure and interactions with basic fibroblast growth factor. Science 271:1116-1120 (1996).
9. S. J. Konturek, T. Brzozowski, J. Majka, A. Szlachcic, W. Bielanski, J. Stachura, and W. Otto. Fibroblast growth factor in gastroprotection and ulcer healing:interaction with sucralfate. Gut 34:881-887 (1993).
10. H. Kuwayama, T. Naito, and Y. Kojima. Proliferative response of rabbit and rat gastric epithelial cells to human epidermal growth factor. Digestion 55:108-114 (1994).
11. H. Paimela, P. J. Goddard, K. Carter, R. Khakee, P. L. McNeil, S. Ito, and W. Silen. Restitution of frog gastric mucosa in vitro: Effect of basic fibroblast growth factor. Gastroenterology 104:1337-1345 (1993).
12. E. Nexo and S. S. Poulsen. Does epidermal growth factor play a role in the action of sucralfate? Scand. J. Gastroent. 22 (Suppl 127):45-49 (1987).
13. S. C. Barranco, C. M. Townsend, C. Casartelli, Jr., B. G. Macik, N. L. Burger, W. R. Boerwinkle, and W. K. Gourley. Establishment and characterization of an in vitro model system for human adenocarcinoma of the stomach. Cancer Res. 43:1703-1709 (1983).
14. H. Zheng, P. K. Shah, and K. L. Audus. Evaluation of antiulcer agents with a human adenocarcinoma cell line (AGS). Int. J. Pharm., 129:103-112 (1996).
15. H. Zheng, P. K. Shah, and K. L. Audus. Primary culture of rat gastric epithelial cells as an in vitro model to evaluate antiulcer agents. Pharm. Res. 11:77-82 (1994).
16. M. Piontek, K. J. Hengels, R. Porschen, and G. Strohmeyer. Antiproliferative effect of tyrosine kinase inhibitors in epidermal growth factor-stimulated growth of gastric cancer cells. Anticancer Res. 13:2119-2123 (1994).
17. A. U. Dignass, S. Tsunekawa, and D. K. Podolsky. Fibroblast growth factors modulate intestinal epithelial cell growth and migration. Gastroenterology 106:1254-1262 (1994).
18. R. Nagashima. Development and characteristics of sucralfate. J. Clin. Gastroenterol. 3(suppl. 2):103-110 (1981).